Interferon-Dependent Engagement of Eukaryotic Initiation Factor 4B via S6 Kinase (S6K)- and Ribosomal Protein S6K-Mediated Signals

REFERENCES

• Alsayed, Y., S. Uddin, S. Ahmad, B. Majchrzak, B. J. Druker, E. N. Fish, and L. C. Platanias. 2000. IFN-gamma activates the C3G/Rap1 signaling pathway. J. Immunol. 164:1800–1806.
   PubMed Web of Science ®Google Scholar
• Bi, X., J. Ren, and D. J. Goss. 2000. Wheat germ translation initiation factor eIF4B affects eIF4A and eIFiso4F helicase activity by increasing the ATP binding affinity of eIF4A. Biochemistry 39:5758–5765.
   PubMedGoogle Scholar
• Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889–5892.
   PubMed Web of Science ®Google Scholar
• Cao, W., S. Manicassamy, H. Tang, S. P. Kasturi, A. Pirani, N. Murthy, and B. Pulendran. 2008. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9:1157–1164.
   PubMed Web of Science ®Google Scholar
• Carayol, N., E. Katsoulidis, A. Sassano, J. K. Altman, B. J. Druker, and L. C. Platanias. 2008. Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway. J. Biol. Chem. 283:8601–8610.
   PubMed Web of Science ®Google Scholar
• Chaudhuri, J., A. Chakrabarti, and U. Maitra. 1997. Biochemical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1. J. Biol. Chem. 272:30975–30983.
   PubMedGoogle Scholar
• Colina, R., M. Costa-Mattioli, R. J. Dowling, M. Jaramillo, L. H. Tai, C. J. Breitbach, Y. Martineau, O. Larsson, L. Rong, Y. V. Svitkin, A. P. Makrigiannis, J. C. Bell, and N. Sonenberg. 2008. Translational control of the innate immune response through IRF-7. Nature 452:323–328.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1420.
   PubMed Web of Science ®Google Scholar
• David, M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721–1723.
   PubMed Web of Science ®Google Scholar
• Dong, Z., and J. T. Zhang. 2003. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol. Biol. Cell 14:3942–3951.
   PubMedGoogle Scholar
• Dong, Z., and J. T. Zhang. 2006. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit. Rev. Oncol. Hematol. 59:169–180.
   PubMedGoogle Scholar
• Dong, Z., L. H. Liu, B. Han, R. Pincheira, and J. T. Zhang. 2004. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23:3790–3801.
   PubMedGoogle Scholar
• Dorrello, N. V., A. Peschiaroli, D. Guardavaccaro, N. H. Colburn, N. E. Sherman, and M. Pagano. 2006. S6K1- and ßTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467–471.
   PubMed Web of Science ®Google Scholar
• Fang, P., V. Hwa, and R. G. Rosenfeld. 2006. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Exp. Cell Res. 312:1229–1239.
   PubMed Web of Science ®Google Scholar
• Gingras, A. C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913–963.
   PubMed Web of Science ®Google Scholar
• Grifo, J. A., R. D. Abramson, C. A. Satler, and W. C. Merrick. 1984. RNA-stimulated ATPase activity of eukaryotic initiation factors. J. Biol. Chem. 259:8648–8654.
   PubMed Web of Science ®Google Scholar
• Grifo, J. A., S. M. Tahara, J. P. Leis, M. A. Morgan, A. J. Shatkin, and W. C. Merrick. 1982. Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA. J. Biol. Chem. 257:5246–5252.
   PubMedGoogle Scholar
• Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926–1945.
   PubMed Web of Science ®Google Scholar
• Hernández, G., and P. Vazquez-Pianzola. 2005. Functional diversity of the eukaryotic translation initiation factors belonging to eIF4 families. Mech. Dev. 122:865–876.
   PubMed Web of Science ®Google Scholar
• Hershey, J. W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717–755.
   PubMed Web of Science ®Google Scholar
• Itoh, S., B. Ding, C. P. Bains, N. Wang, Y. Takeishi, T. Jalili, G. L. King, R. A. Walsh, C. Yan, and J. Abe. 2005. Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation. J. Biol. Chem. 280:24135–24142.
   PubMedGoogle Scholar
• Jaramillo, M., T. E. Dever, W. C. Merrick, and N. Sonenberg. 1991. RNA unwinding in translation: assembly of helicase complex intermediates comprising eukaryotic initiation factors eIF-4F and eIF-4B. Mol. Cell. Biol. 11:5992–5997.
   PubMed Web of Science ®Google Scholar
• Katsoulidis, E., Y. Li, P. Yoon, A. Sassano, J. Altman, P. Kannan-Thulasiraman, L. Balasubramanian, S. Parmar, J. Varga, M. S. Tallman, A. Verma, and L. C. Platanias. 2005. Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res. 65:9029–9037.
   PubMed Web of Science ®Google Scholar
• Kaur, S., A. Sassano, B. Dolniak, S. Joshi, B. Majchrzak-Kita, D. P. Baker, N. Hay, E. N. Fish, and L. C. Platanias. 2008. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 105:4808–4813.
   PubMed Web of Science ®Google Scholar
• Kaur, S., L. Lal, A. Sassano, B. Majchrzak-Kita, M. Srikanth, D. P. Baker, E. Petroulakis, N. Hay, N. Sonenberg, E. N. Fish, and L. C. Platanias. 2007. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J. Biol. Chem. 282:1757–1768.
   PubMed Web of Science ®Google Scholar
• Kaur, S., E. Katsoulidis, and L. C. Platanias. 2008. Akt and mRNA translation by interferons. Cell Cycle 7:2112–2116.
   PubMed Web of Science ®Google Scholar
• Kaur, S., S. Uddin, and L. C. Platanias. 2005. The PI 3′ kinase pathway in interferon signaling. J. Interferon Cytokine Res. 25:780–787.
   PubMed Web of Science ®Google Scholar
• Lekmine, F., A. Sassano, S. Uddin, J. Smith, B. Majchrzak, S. M. Brachmann, N. Hay, E. N. Fish, and L. C. Platanias. 2004. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp. Cell Res. 295:173–182.
   PubMedGoogle Scholar
• Lekmine, F., S. Uddin, A. Sassano, S. Parmar, S. M. Brachmann, B. Majchrzak, N. Sonenberg, N. Hay, E. N. Fish, and L. C. Platanias. 2003. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J. Biol. Chem. 278:27772–27780.
   PubMed Web of Science ®Google Scholar
• Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651–662.
   PubMed Web of Science ®Google Scholar
• Li, Y., A. Sassano, B. Majchrzak, D. K. Deb, D. E. Levy, M. Gaestel, A. R. Nebreda, E. N. Fish, and L. C. Platanias. 2004. Role of p38alpha Map kinase in type I interferon signaling. J. Biol. Chem. 279:970–979.
   PubMed Web of Science ®Google Scholar
• Liu, Z., Z. Dong, Z. Yang, Q. Chen, Y. Pan, Y. Yang, P. Cui, X. Zhang, and J. T. Zhang. 2007. Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development. Differentiation 75:652–661.
   PubMedGoogle Scholar
• Mayer, I. A., A. Verma, I. M. Grumbach, S. Uddin, F. Lekmine, F. Ravandi, B. Majchrzak, S. Fujita, E. N. Fish, and L. C. Platanias. 2001. The p38 Map kinase pathway mediates the growth inhibitory effects of IFNα in BCR-ABL expressing cells. J. Biol. Chem. 276:28570–28577.
   PubMed Web of Science ®Google Scholar
• Methot, N., M. S. Song, and N. Sonenberg. 1996. A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol. Cell. Biol. 16:5328–5334.
   PubMed Web of Science ®Google Scholar
• Parmar, S., and L. C. Platanias. 2003. Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15:431–439.
   PubMedGoogle Scholar
• Parmar, S., J. Smith, A. Sassano, S. Uddin, E. Katsoulidis, B. Majchrzak, S. Kambhampati, E. A. Eklund, M. S. Tallman, E. N. Fish, and L. C. Platanias. 2005. Differential regulation of the p70 S6 kinase pathway by interferon alpha and imatinib mesylate (STI571) in chronic myelogenous leukemia cells. Blood 106:2436–2443.
   PubMed Web of Science ®Google Scholar
• Pause, A., G. J. Belsham, A. C. Gingras, O. Donzé, T. A. Lin, J. C. Lawrence, Jr., and N. Sonenberg. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371:762–767.
   PubMed Web of Science ®Google Scholar
• Pende, M., S. H. Um, V. Mieulet, M. Sticker, V. L. Goss, J. Mestan, M. Mueller, S. Fumagalli, S. C. Kozma, and G. Thomas. 2004. S6K1−/−/S6K2−/− mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 24:3112–3124.
   PubMed Web of Science ®Google Scholar
• Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727–777.
   PubMed Web of Science ®Google Scholar
• Pitha-Rowe, I. F., and P. M. Pitha. 2007. Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev. 18:409–417.
   PubMedGoogle Scholar
• Platanias, L. C. 2003. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol. Ther. 98:129–142.
   PubMed Web of Science ®Google Scholar
• Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat. Rev. Immunol. 5:375–386.
   PubMed Web of Science ®Google Scholar
• Platanias, L. C., and E. N. Fish. 1999. Signaling pathways activated by interferons. Exp. Hematol. 27:1583–1592.
   PubMed Web of Science ®Google Scholar
• Raught, B., F. Peiretti, A. C. Gingras, M. Livingstone, D. Shahbazian, G. L. Mayeur, R. D. Polakiewicz, N. Sonenberg, and J. W. Hershey. 2004. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO. J. 23:1761–1769.
   PubMed Web of Science ®Google Scholar
• Ritchie, K. J., and D. E. Zhang. 2004. ISG15: the immunological kin of ubiquitin Semin. Cell Dev. Biol. 15:237–246.
   Google Scholar
• Rozen, F., I. Edery, K. Meerovitch, T. E. Dever, W. C. Merrick, and N. Sonenberg. 1990. Bidirectional RNA helicase activity of eukaryotic translation initiation factors 4A and 4F. Mol. Cell. Biol. 10:1134–1144.
   PubMed Web of Science ®Google Scholar
• Rozovsky, N., A. C. Butterworth, and M. J. Moore. 2008. Interactions between eIF4AI and its accessory factors eIF4B and eIF4H. RNA 14:2136–2148.
   PubMed Web of Science ®Google Scholar
• Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282:20059–20063.
   PubMed Web of Science ®Google Scholar
• Shahbazian, D., P. P. Roux, V. Mieulet, M. S. Cohen, B. Raught, J. Taunton, J. W. Hershey, J. Blenis, M. Pende, and N. Sonenberg. 2006. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO. J. 25:2781–2791.
   PubMed Web of Science ®Google Scholar
• Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227–264.
   PubMed Web of Science ®Google Scholar
• Thyrell, L., L. Hjortsberg, V. Arulampalam, T. Panaretakis, S. Uhles, M. Dagnell, B. Zhivotovsky, I. Leibiger, D. Grandér, and K. Pokrovskaja. 2004. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J. Biol. Chem. 279:24152–24162.
   PubMed Web of Science ®Google Scholar
• Uddin, S., B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, R. Pine, P. R. Young, E. N. Fish, and L. C. Platanias. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274:30127–30131.
   PubMed Web of Science ®Google Scholar
• Uddin, S., L. Yenush, X. J. Sun, M. E. Sweet, M. F. White, and L. C. Platanias. 1995. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem. 270:15938–15941.
   PubMed Web of Science ®Google Scholar
• Wullschleger, S., R. Loewith, and M. N. Hall. 2006. mTOR signaling in growth and metabolism. Cell 124:471–484.
   PubMed Web of Science ®Google Scholar
• Zhang, H. M., J. Yuan, P. Cheung, D. Chau, B. W. Wong, B. M. McManus, and D. Yang. 2005. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol. Cell. Biol. 25:6247–6258.
   PubMedGoogle Scholar